-
Stemline Therapeutics To Go Private In $667M Transaction
Monday, May 4, 2020 - 10:16am | 465The New York-based oncology-focused, commercial-stage biopharma Stemline Therapeutics Inc (NASDAQ: STML) ringed in merger Monday with a go-private deal valued at up to $667 million. Stemline said it has entered a definitive agreement to be bought by privately held Italian pharma and...